AbdullahM. S.Al-OsaimiMDFACP, FACG, AGAF

PubMed

• 4 citations
  Two-year outcomes of balloon-occluded retrograde transvenous obliteration of gastric varices in liver transplant recipients: A multi-institutional study
  Wael E. Saad, Jeffrey Forris Beecham Chick, Rajiv N. Srinivasa, Nael Saad, Seung Kwon Kim
  Diagnostic and Interventional Imaging. 2017-11-01
• 68 citations
  Liver Transplantation in the Obese Cirrhotic Patient.
  Erin Spengler, Jacqueline G. O'Leary, Helen S. Te, Shari S. Rogal, Anjana Pillai
  Transplantation. 2017-10-01
• 7 citations
  Readability of Healthcare Literature for Hepatitis B and C
  Andrew Meillier, Shyam Patel, Abdullah M. S. Al-Osaimi
  Digestive Diseases and Sciences. 2015-07-24

Journal Articles

• Management Of Bleeding Duodenal Varices With Combined Tips-Decompression And Trans-Tips Transvenous Obliteration Utilizing 3% Sodium Tetradecyl Sulfate Foam Sclerosis  
  Saad WE, Lippert A, Schwaner S, Al-Osaimi AMS, Sabri S, Saad N, J Clin Imaging Sci, 1/1/2014
• Approach to the Management of Portal Hypertensive Gastropathy and Gastric Antral Vascular Ectasia  
  Qureshi K, Al-Osaimi AMS, Gastroenterol Clin N Am, 1/1/2014
• Management of Gastric Varices  
  Uppal D, Henry Z, Al-Osaimi A, Saad W, Caldwell S, Curr Hepatology Rep, 1/1/2014
• Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy  
  Afdhal NH, Dusheiko GM, Giannini EG, Chen PJ, Han KH, Mohsin A, Rodriguez-Torres M, Rugina S, Bakulin I, Lawitz E, Shiffman ML, Tayyab GU, Poordad F, Kamel YM, Brainsk..., Gastroenterology, 1/1/2014
• Efficacy and safety of Boceprevir plus peginterferon–ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis  
  Bruno S, Vierling JM, Esteban R, Nyberg LM, Tanno H, Goodman Z, Poordad F, Bacon B, Gottesdiener K, Pedicone LD, Albrecht JK, Brass C, Burroughs H (Al-Osaimi, AMS: Uni..., J Hepatol, 1/1/2013
• Hormonal effects on Nodular GAVE  
  Brijbassie A, Al-Osaimi A, Powell SM, Gastroenterol Res, 1/1/2013
• Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study  
  Freeman J, Emond J, Gillespie BW, Appelbaum PS, Weinrieb R, Hill-Callahan P, Gordon EJ, Terrault N, Trotter J, Ashworth A, Dew MA, Pruett T; A2ALL Study Group (Al-Osai..., Clin Transplant, 1/1/2013
• Anemia during treatment with peginterferon alfa-2b/ribavirin and Boceprevir: Analysis from the SPRINT-2 trial  
  Sulkowski MS, Poordad F, Manns MP, Bronowicki JP, Reddy KR, Harrison SA, Afdhal NH, Sings HL, Pedicone LD, Koury KJ, Sniukiene V, Burroughs MH, Albrecht JK, Brass CA, ..., Hepatology, 1/1/2013
• Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection  
  Flamm SL, Lawitz E, Jacobson I, Bourlière M, Hezode C, Vierling JM, Bacon BR, Niederau C, Sherman M, Goteti V, Sings HL, Barnard RO, Howe JA, Pedicone LD, Burroughs MH..., Clin Gastroenterol Hepatol, 1/1/2013
• Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-alpha-induced depression in patients with chronic hepatitis C  
  Smith AK, Simon JS, Gustafson EL, Noviello S, Cubells JF, Epstein MP, Devlin DJ, Qiu P, Albrecht JK, Brass CA, Sulkowski MS, McHutchinson JG, Miller AH (Al-Osaimi, AMS..., Mol Psychiatry, 1/1/2012
• Does external beam radiation improve survival following transarterial chemoembolization for unresectable hepatocellular carcinoma?  
  Cupino AC, Hair CD, Angle JF, Caldwell SH, Rich TA, Arslan B, Berg CL, Northup PG, Al-Osaimi AMS, Argo CK, Gastrointest Cancer Res, 1/1/2012
• Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and de...  
  Clark PJ, Thompson AJ, Zhu M, Vock DM, Zhu Q, Ge D, Patel K, Harrison SA, Urban TJ, Naggie S, Fellay J, Tillmann HL, Shianna K, Noviello S, Pedicone LD, Esteban R, Kwo..., J Viral Hepat, 1/1/2012
• The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection  
  Clark PJ, Thompson AJ, Zhu Q, Vock DM, Zhu M, Patel K, Harrison SA, Naggie S, Ge D, Tillmann HL, Urban TJ, Shianna K, Fellay J, Goodman Z, Noviello S, Pedicone LD, Afd..., Dig Dis Sci, 1/1/2012
• Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with Boceprevir and peginterferon/ribavirin  
  Jacobson IM, Marcellin P, Zeuzem S, Sulkowski MS, Esteban R, Poordad F, Bruno S, Burroughs MH, Pedicone LD, Boparai N, Deng W, DiNubile MJ, Gottesdiener KM, Brass CA, ..., Hepatology, 1/1/2012
• Factors that predict response of patients with hepatitis C virus infection to Boceprevir  
  Poordad F, Bronowicki JP, Gordon SC, Zeuzem S, Jacobson IM, Sulkowski MS, Poynard T, Morgan TR, Molony C, Pedicone LD, Sings HL, Burroughs MH, Sniukiene V, Boparai N, ..., Gastroenterology, 1/1/2012
• Racial differences in hepatitis C treatment eligibility  
  Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Novie..., Hepatology, 1/1/2011
• Bleeding Gastric Varices Obliteration with BRTO (Balloon-Occluded Retrograde Transvenous Obliteration) utilizing sodium tetradecyl sulfate foam  
  Sabri SS, Swee W, Turba UC, Saad WEA, Park AW, Al-Osaimi AM, Caldwell SH, Matsumoto AH, Angle JF, J Vasc Interv Radiol, 1/1/2011
• Hepatitis C treatment among racial and ethnic groups in the IDEAL trial  
  Muir AJ, Hu KQ, Gordon SC, Koury K, Boparai N, Noviello S, Albrecht JK, Sulkowski MS, McCone J (Al-Osaimi, AMS: University of Virginia Principle Investigator), J Viral Hepat, 1/1/2011
• Boceprevir for untreated chronic HCV genotype 1 infection  
  Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Brono..., N Engl J Med, 1/1/2011
• Sorafenib before Liver Transplantation for Hepatocellular Carcinoma: Risk or Give up?  
  Northup PG, Truesdale AE, Caldwell SH, Shah NL, Argo CK, Al-Osaimi AMS, Schmitt TM, Transpl Int, 1/1/2011
• Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate  
  Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK,..., Gastroenterology, 1/1/2010
• Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus  
  Thompson AT, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, Urban T, Afdhal NH, Jacobson IM, Esteban R, Poordad F, Lawitz EJ, McCone J, Shiffman ML, Galler GW, Lee..., Gastroenterology, 1/1/2010
• Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection  
  McHutchison J, Goodman Z, Patel K, Makhlouf H, Rodriguez-Torres M, Shiffman M, Rockey D, Husa P, Chuang WL, Levine R, Jonas M, Theodore D, Brigandi R, Webster A, Schul..., Gastroenterology, 1/1/2010
• ITPA gene variants protect against anemia in patients treated for chronic hepatitis C Letter  
  Fellay J, Thompson AT, Ge D, Gumbs CE, Urban TJ, Shianna KV, Little LD, Qiu P, Bertelsen AH, Watson M, Warner A, Muir AJ, Brass C, Albrecht J, Sulkowski M, McHutchison..., Nature, 1/1/2010
• Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy  
  Harrison SA, Rossaro L, Hu KQ, Patel K, Tillmann H, Dhaliwal S, Torres DM, Koury K, Goteti VS, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS; (Al-Osa..., Hepatology, 1/1/2010
• Join now to see all

Books/Book Chapters

• Portal Hypertension and Liver Transplantation. 3RD. SIR Syllabus 
  Chapter: Clinical Presentation of Liver Cirrhosis and Portal Hypertension. 
  Ismail M, Al-Osaimi AMSEditors: Saad W.2013
• Portal Hypertension and Liver Transplantation. 3RD. SIR Syllabus 
  Chapter: Endoscopic Classification and Management of Varices. 
  Arner D, Caldwell SH, Al-Osaimi AMSEditors: Saad W.2013
• Portal Hypertension and Liver Transplantation. 3RD. SIR Syllabus 
  Chapter: Medical Management of Portal Hypertension. 
  Bleibel W, Al-Osaimi AMSEditors: Saad W.2013
• Schiff’s Diseases of the Liver. 
  Chapter: Non-alcoholic Fatty Liver Disease. 
  Page 868 - 908Caldwell SH, Argo C, Al-Osaimi AMSEditors: Schiff ER, Maddrey WC, Sorrell MF.John Wiley & Sons, Ltd., Baltimore, MDEdition 11th,2012
• Schiff’s Diseases of the Liver. Volume 2. 
  Chapter: Non-alcoholic Fatty Liver Disease. 
  Page 1117 - 1167Caldwell SH, Argo C, Al-Osaimi AMSEditors: Schiff ER, Sorrell MF, Maddrey WC.Lippincott Williams and Wilkins, Baltimore, MDEdition 10th,2007
• Frontiers in Hepatology: NASH and Nutritional Therapy. 
  Chapter: Nonalcoholic fatty liver (NAFL): Overview. 
  Page 1 - 43Caldwell SH, Al-Osaimi AMS, Chang C, Davis C, Hespenheide EE, Krunger-Higby L, Hylton AI, Iezzoni JC, Le TH, Nakamoto RK, Redick J, Peterson TEditors: Okita K.Springer-Verlag, Tokyo, Japan2005
• Progress in the treatment of liver disease. 
  Chapter: Diagnosis and treatment of nonalcoholic fatty liver in adults. 
  Page 233 - 252Caldwell SH, Al-Osaimi AMSEditors: Arroyo V, Forns X, Garcia-Pagan JC, Rodes J.Ars Medica, Spain2003
• Join now to see all

Abstracts/Posters

• Intractable Pruritus in Liver Disease Treated with Therapeutic Plasma Exchange.
  Gautam SC, Al-Osaimi A, Balogun RA, J Clin Apheresis, 1/1/2013
• Virologic Response Rates are Similar in Previously Untreated and Previously Treated and Relapsed Patients Receiving Boceprevir Triple Therapy: A Retrospective analysis.
  Bacon BR, Poordad F, Bronowicki J-P, Esteban R, Thompson S, Helmond F (Al-Osaimi, AMS: University of Virginia Principle Investigator), J Hepatol, 1/1/2013
• Safety and Efficacy of Boceprevir /PEG-Interferon/Ribavirin (BOC/P/R) Combination Therapy for Chronic HCV G1 Patients with Compensated Cirrhosis: A Mate-Analysis of Fi...
  Vierling JM, Zeuzem S, Poordad F, Bronowicki J-P, Manns MP, Bacon BR, Esteban R, Flamm SL, Kwo PY, Pedicone LD, Deng W, Dutko FJ, DiNubile MJ, Koury KJ, Helmond FA, Wa..., J Hepatol, 1/1/2013
• Use of Photodynamic Th erapy as a Novel Approach for Providing Local Control of Cholangiocarcinoma in Patients Awaiting Protocol Liver Transplantation.
  Cosgrove N, Maluf D, Sanoff H, Morris M, Read P, Mann J, Green C, Argo C, Al-Osaimi A, Berg C, Wang A, Am J Gastroenterol, 1/1/2012
• Peripheral Blood Platelet Count Predicts Post-Tips Mortality in Patients With Cirrhosis.
  Bleibel W, Saad W, Sheeran D, Anderson CL, Northup PG, Al-Osaimi AM, Gastroenterology, 1/1/2012
• Albumin and MELD score predict decompensation in patients with HCV cirrhosis and thrombocytopenia on interferon therapy: analysis from the ENABLE studies.
  Afdhal N, Giannini EG, Sigal S, Gordon SC, Everson GT, Al-Osaimi AM, Dusheiko GM, Casanovas T, Brau N, Vasey SY, Iyengar M, Forssen U, Campbell FM, Theodore D, Hepatology, 1/1/2012
• Clinical Decision Tool for Predicting Treatment Week Eight Response and Sustained Virologic Response in Patients Treated with Boceprevir (BOC) Plus Peginterferon Alfa ...
  Devine S, Kattan MW, Muir AJ, Pedicone L, Poordad F, Poynard T, Sulkowski MS, Thompson AJ (Al-Osaimi, AMS: University of Virginia Principle Investigator), Hepatology, 1/1/2012
• Boceprevir (BOC) Combined with Peginterferon alfa-2b/ribavirin (P/RBV) in Treatment-Naïve Chronic HCV Genotype 1 Patients with Compensated Cirrhosis: Sustained Virolog...
  Lawitz E, Zeuzem S, Nyberg LM, Nelson DR, Rossaro L, Balart LA, Reddy KR, Morgan T, Deng W, Koury KJ, Alves K, Dutko F, Wahl J, Pedicone L, Poordad F (Al-Osaimi, AMS: ..., Hepatology, 1/1/2012
• Results of ENABLE 2, a Phase 3, Multicenter Study of Eltrombopag and PegInterferon Alfa-2b Treatment in Patients with Hepatitis C and Thrombocytopenia.
  Dusheiko G, Afdhal N, Giannini EG, Chen PJ, Han KH, Rodriguez-Torres M, Rugina S, Lawitz E, Streinu-Cercel A, Shiffman ML, Poordad F, Kamel YM, Brainsky A, Geib J, Vas..., J Hepatol, 1/1/2012
• A Randomized Trial Comparing Ribavirin Dose Reduction versus Erythropoietin for Anemia Management in Previously Untreated Patients with Chronic Hepatitis C Receiving B...
  Poordad FF, Lawitz EJ, Reddy KR, Afdhal NH, H´ezode C, Zeuzem S, Lee SS, Calleja JL, Brown Jr. RS, Craxi A, Wedemeyer H, Deng W, Koury K, Boparai N, Pedicone LD, Burro..., J Hepatol, 1/1/2012
• High SVR with regular interferon-base therapy than PEG-IFN and RBV for chronic hepatitis C post liver transplantation.
  Al-Osaimi AMS, Roman AL, Flohr TR, Vaughn BL, Northup PG, Argo CK, Shah NL, Schmitt TM, Kumer SC, Berg CL, European Association for the Study of the Liver (EASL) Special Conference: Liver Transplantation, Lisbon, Portugal, 1/15/2011
• The Effect of Balloon-occluded Retrograde Transvenous Obliteration (BRTO) on the Model for End Stage Liver Disease (MELD) Score.
  Saad W, Darwish W, Anderson, Sabri S, Al-Osaimi AMS, Angle JF, Caldwell S, J Vasc Intervent Radiol; SIR (Society of Interventional Radiology) 36TH Annual Scientific Meeting, Chicago, IL, 1/1/2011
• Evaluating Accuracy of Cardiac Risk Stratification Pre-Liver Transplant.
  Shah N, Northup P, Kumer S, Argo C, Al-Osaimi A, Schmitt T, Lapinsky E, Am J Gastroenterol, 1/1/2011
• Pulmonary Arterial Hypertension: A Cause of Abnormal Liver Function Tests of Unknown Etiology.
  Bleibel WA, Guerreo J, Barza M, Al-Osaimi AMS, Gastroenterology, 1/1/2011
• Implementing a Treatment Protocol Reduces Inpatient Cost of Hepatic Encephalopathy.
  Bleibel WA, Quatrara B, Melo I, Romeo L, Berg CL, Caldwell SH, Argo CK, Northup PG, Shah NL, Al-Osaimi AMS, Gastroenterology, 1/1/2011
• Sustained Virologic Response and Boceprevir Resistance-Associated Variants Observed in Patients Infected With HCV Genotype 1A/1b When Treated With Boceprevir Plus Pegi...
  Brass CA, Barnard RJ, Howe JA, Ogert RA, Ralston R, Boparai N, Burroughs M, Sniukiene V, Mendez P, Albrecht JK (Al-Osaimi, AMS: University of Virginia Principle Invest..., Gastroenterology, 1/1/2011
• Boceprevir in Addition to Standard of Care Enhanced SVR in Hepatitis C Virus (HCV) Genotype-1 With Advanced Fibrosis/Cirrhosis: Subgroup Analysis of SPRINT-2 and RESPO...
  Bruno S, Vierling JM, Esteban R, Nyberg LM, Tanno H, Albrecht JK, Brass CA, Boparai N, Sniukiene V, Burroughs M (Al-Osaimi, AMS: University of Virginia Principle Inves..., Gastroenterology, 1/1/2011
• Thyroid Stimulating Hormone (TSH) and Peginterferon Treatment Induced Hypothyroidism May Be Associated With Phosphodiesterase Polymorphisms in Patients With Chronic He...
  Clark P, Thompson AJ, Zhu M, Ge D, Shianna K, Tillmann HL, Patel K, Urban T, Singh A, Sulkowski M, Afdhal N, Jacobson IM, Esteban R, Poordad F, Lawitz EJ, McCone J, Sh..., Gastroenterology, 1/1/2011
• Projecting the Clinical Impact of Therapeutic Regimens Including Boceprevir in Previously Untreated Adult Subjects With Chronic Hepatitis C Genotype 1.
  Ferrante SA, Chhatwal J, Dasbach EJ, Sniukiene V, Poordad F, Bronowicki J-P, El Khoury A, Brass CA (Al-Osaimi, AMS: University of Virginia Principle Investigator), Gastroenterology, 1/1/2011
• High Sustained Virologic Response (SVR) Among Genotype 1 Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated with Boceprevir (BOC) Plus Pe...
  Flamm SL, Lawitz EJ, Jacobson IM, Rubin RA, Bourliere M, Hezode C, Vierling J, Niederau C, Sherman M, Goteti VS, Vilchez RA, Brass CA, Albrecht JK, Poordad F (Al-Osaim..., Gastroenterology, 1/1/2011
• Adherence to Assigned Dosing Regimen and Sustained Virologic Response Among Hepatitis C Genotype 1 Treatment-Naïve and PEG/Ribavirin Treatment-Failures Treated With Bo...
  Gordon SC, Lawitz EJ, Bacon BR, Sulkowski M, Yoshida EM, Davis MN, Boparai N, Sniukiene V, Burroughs M, Brass CA, Albrecht JK, Reddy R(Al-Osaimi, AMS: University of Vi..., Gastroenterology, 1/1/2011
• Frequencies of Resistance-Associated Amino Acid Variants Detected by 454 Sequencing During Combination Treatment With Boceprevir Plus Pegintron (Peginterferon Alfa-2B)...
  Howe JA, Qiu P, Ogert RA, Mendez P, Brass CA, Albrecht JK, Ralston R, Barnard RJ, Hazuda D (Al-Osaimi, AMS: University of Virginia Principle Investigator), Gastroenterology, 1/1/2011
• Gender Differences in Hepatitis C Virus (HCV) Treatment Outcomes With Peginterferon (pegIFN) Plus Ribavirin (RBV): An Analysis of the IDEAL Study.
  Loubser K, Lawitz EJ, Shiffman ML, McHutchison J, Muir AM, Galler G, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Long J, Noviello S, Brass CA, Pedicone LD, Albr..., Gastroenterology, 1/1/2011
• Overall Safety Profile of Boceprevir Plus Peginterferon Alfa-2B/Ribavirin.
  Manns MP, Felizarta F, Schiff ER, Burroughs M, Sniukiene V, Boparai N, Brass CA, Albrecht JK, Vierling JM (Al-Osaimi, AMS: University of Virginia Principle Investigator), Gastroenterology, 1/1/2011
• Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in Naïve and Peginterferon Alfa-2B/Ribavirin Previous-Treatment...
  Manns MP, Poordad F, Bacon BR, Bruno S, Esteban R, Silva MO, Buti M, Burroughs M, Sniukiene V, Boparai N, Brass CA, Albrecht JK, Bronowicki J-P (Al-Osaimi, AMS: Univer..., Gastroenterology, 1/1/2011
• Join now to see all

Lectures

• Liver Transplantation 
  Abington Memorial Hospital, Philadelphia, NJ - 1/7/2015
• Chronic Hepatitis C: In the Era of Interferon Free Regimen 
  Red Banks, NJ - 1/28/2014
• Chronic Hepatitis C Treatent in the Era of Interferon Free Regimen 
  Delaware County Hospital, Philadelphia, NJ - 1/26/2014
• Chief's Case Presentation Expert. 
  Student/Faculty Building - 1/25/2014
• Post-Transplant Lymphoproliferative Disorders (PTLD) in Liver Transplant Recipient 
  Thomas Jefferson University - 1/14/2014
• Chief's: CPC Residents Program, Invited lecturer 
  TUHS, School of Medicine, Erny Auditorium - 1/7/2014
• Chief's: CPC Residents Program 
  University of Virginia Health Sciences Center, Erny Auditorium - 1/7/2014
• Therapeutic Update on the Management of Fatty Liver Disease 
  Philadelphia, PA - 1/6/2014
• Management of Cirrhotic in the in-Patient Setting 
  Erny Auditorium - 1/4/2014
• Nonalcoholic Steatohepatitis: Health and Societal Impact 
  Jeddah, Saudi Arabia - 1/4/2014
• Chronic HCV: Updates in the Era of IFN-Free Regimen. 
  TUHS, School of Medicine, Erny Auditorium - 1/3/2014
• Chronic HCV: Updates In the Era of IFN-Free Regimen 
  Medicine Residents’ Library - 1/2/2014
• Chronic HCV: Updates In the Era of IFN-Free Regimen 
  TUHS, School of Medicine. Medicine Residents’ Library - 1/2/2014
• Management of Gastric Varices 
  Temple University, Philadelphia, PA - 1/20/2013
• Management of Gastric Varices. Invited Grand Round Lecturer 
  Temple University, Philadelphia, PA - 1/20/2013
• Chief's Case Presentation Expert 
  University of Virginia Health Sciences Center, Student/Faculty Building - 1/19/2013
• NAFLD: Clinical Assessment 
  Jeddah, Saudi Arabia - 1/14/2013
• NASH: Is there a Treatment 
  Jeddah, Saudi Arabia - 1/14/2013
• Prevention of recurrent Hepatitis B after Liver Transplantation 
  University of Dammam, School of Medicine, Dammam, Saudi Arabia - 1/9/2013
• Acute on Chronic Liver Failure: How can we recognize it? 
  University of Dammam, School of Medicine, Dammam, Saudi Arabia - 1/8/2013
• HCV Screening and Linkage to Care: The First Step to a Cure 
  Norfolk, VA - 1/6/2013
• HCV Screening and Linkage to Care: 
  Norfolk, VA - 1/6/2013
• Anatomy and Hemodynamics of Ectopic Varices (Gastric and non-Gastric) Varices: Endoscopic and Vascular Classifications. 
  Chicago, IL - 1/1/2013
• HCV Updates in the Era of Interferon-Free Therapy 
  King Fahad Medical City, Riyadh, Saudi Arabia - 1/1/2013
• Management of Cirrhotic Patients 
  King Khalid University Hospital, School of Medicine, King Saud University, Riyadh, Saudi Arabia - 1/25/2012
• Join now to see all

Other

• Nonalcoholic Fatty Liver Disease; Physicians Practice –UVA journal for marketing publication targeting referring physicians in Virginia 
  Al-Osaimi AMS
  1/1/2010
• The liver biopsy technique for the BARD needle, corporate video. 
  Al-Osaimi AMS